Publications by authors named "Ana Collazo"

Claim this Profile
T
The Association of Retinal Capillary Density and Retinal Thickness in Diabetic Retinopathy.
Rose Tan, Anoush Shahidzadeh, Ana Collazo, Xuejuan Jiang, Andrew A Moshfeghi

Invest Ophthalmol Vis Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study.
María Torrente, Pedro A Sousa, Roberto Hernández, Mariola Blanco, Virginia Calvo, Ana Collazo

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of quality of life with performance status, circadian rhythm, and activity level of lung cancer patients using wearable devices as ambulatory monitoring.
Maria Torrente, Pedro A Sousa, Fabio Franco, Ernestina Mensalvas, Virginia Calvo, Ana Collazo

Clin Med (Lond)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal tissue content impact on the GBM molecular classification.
Rodrigo Madurga, Noemí García-Romero, Beatriz Jiménez, Ana Collazo, Francisco Pérez-Rodríguez

Brief Bioinform· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.
Atocha Romero, Eloisa Jantus-Lewintre, Beatriz García-Peláez, Ana Royuela, Amelia Insa, Ana Collazo

Mol Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer.
Jordi Remon, Ana Collazo, Beatriz Jimenez

Transl Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.
Carmen Blanco-Aparicio, Ana María García Collazo, Julen Oyarzabal, Juan F Leal, María Isabel Albarán

Cancer Lett· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis